<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article article-type="editorial" dtd-version="1.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Physiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Physiol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1809357</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2026.1809357</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Exploring the physiological and molecular benefits of physical exercise in cardiovascular diseases</article-title>
<alt-title alt-title-type="left-running-head">Improta-Caria and Aras J&#xfa;nior</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2026.1809357">10.3389/fphys.2026.1809357</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Improta-Caria</surname>
<given-names>Alex Cleber</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1748516"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aras J&#xfa;nior</surname>
<given-names>Roque</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1518877"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Laboratory of Biochemistry and Molecular Biology of the Exercise, University of Sao Paulo (USP)</institution>, <city>S&#xe3;o Paulo</city>, <country country="BR">Brazil</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Faculty of Medicine, Federal University of Bahia (UFBA)</institution>, <city>Salvador</city>, <state>Bahia</state>, <country country="BR">Brazil</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Alex Cleber Improta-Caria, <email xlink:href="mailto:aleximprotacaria@gmail.com">aleximprotacaria@gmail.com</email>
</corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-25">
<day>25</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>17</volume>
<elocation-id>1809357</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>02</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Improta-Caria and Aras J&#xfa;nior.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Improta-Caria and Aras J&#xfa;nior</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-25">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<kwd-group>
<kwd>cardiovascular diseases</kwd>
<kwd>exercise training</kwd>
<kwd>molecular adaptations</kwd>
<kwd>physical exercise</kwd>
<kwd>physiological adaptations</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This study was partly funded by S&#xe3;o Paulo Research Foundation (FAPESP) grants (&#x23;2022/02339-4; &#x23;2024/17783-2).</funding-statement>
</funding-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="10"/>
<page-count count="00"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Integrative Physiology</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes notes-type="frontiers-research-topic">
<p>Editorial on the Research Topic <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/66716">Exploring the physiological and molecular benefits of physical exercise in cardiovascular diseases</ext-link>
</p>
</notes>
</front>
<body>
<p>Cardiovascular diseases (CVDs) are the leading cause of death worldwide (<xref ref-type="bibr" rid="B9">Stark et al., 2025</xref>). Several strategies are used to inhibit the development or progression of CVDs, and one of them is through exercise training (ExT). ExT is widely recognized as an excellent non-pharmacological tool for promoting various benefits to the cardiovascular (<xref ref-type="bibr" rid="B4">Improta-Caria et al., 2024</xref>), neurological (<xref ref-type="bibr" rid="B8">Roever et al., 2023</xref>), and other systems.</p>
<p>Many of the physiological benefits of ExT in individuals with CVDs have already been described in the literature (<xref ref-type="bibr" rid="B3">Hastings et al., 2024</xref>), however, the benefits at the molecular level still need to be further explored. Thus, in this special edition, we have gathered articles that address the impact of different types of ExT on the cardiovascular system and on CVDs, showing the effects of ExT at the molecular level.</p>
<p>ExT can be mainly divided into 2 different types: aerobic ExT (<xref ref-type="bibr" rid="B2">De Sousa and Improta-Caria, 2022</xref>) and resistance ExT (<xref ref-type="bibr" rid="B6">Paluch et al., 2024</xref>), and more recently, more evidence has emerged about high intensity interval training (HIIT) (<xref ref-type="bibr" rid="B10">Wewege et al., 2018</xref>). Aerobic ExT is the most suitable for individuals with CVDs. In this context, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2025.1558678">Improta-Caria et al.</ext-link> demonstrated that 5 weeks of aerobic ExT was able to reduce collagen content in the hearts of mice with chronic Chagas cardiomyopathy, as well as decrease collagen content in skeletal muscles. This beneficial effect of ExT in reducing collagen in cardiac tissue promoted improvement in cardiac arrhythmias, attenuating cardiac dysfunction in these animals. It is important to emphasize that chronic Chagas cardiomyopathy is a disease that induces an increased inflammatory and fibrotic profile in both cardiac and skeletal muscle (<xref ref-type="bibr" rid="B5">Meira et al., 2019</xref>), in addition to promoting severe arrhythmias and cardiac dysfunction (<xref ref-type="bibr" rid="B1">Bocchi et al., 2017</xref>).</p>
<p>In this context, ExT is a key tool in cardiac rehabilitation, both for chronic Chagas cardiomyopathy and other types of cardiomyopathies (<xref ref-type="bibr" rid="B7">Price et al., 2016</xref>). The work of <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2025.1651589">You et al.</ext-link> demonstrated the importance of cardiac rehabilitation by bringing a new perspective based on integrative physiology. This interesting review demonstrated how ExT protects the heart, showing that the effects of ExT promote beneficial crosstalk between the heart and other organs such as skeletal muscle, brain, kidney, gut, liver, and adipose tissue, in addition to explaining some modifications in epigenetic regulation induced by ExT.</p>
<p>The modifications in epigenetic regulation induced by ExT are a new and increasingly evolving topic in current science. In this regard, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcvm.2025.1579352">Yuan et al.</ext-link> explained the impacts of ExT on the expression of microRNAs (miRNAs), and how these impacts on miRNA modulation promote cardioprotection, inducing beneficial changes in some important biological processes such as inflammation, oxidative stress, endothelial function, and cardiac remodeling. In addition to changes in miRNA expression, this important review explains that ExT also induces modifications in the expression of long non-coding chromosomes, DNA methylation, and histone acetylation, promoting improved mitochondrial function, reduced inflammation, decreased fibrotic profile, and improved cardiovascular resilience.</p>
<p>In this context, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2025.1701689">Silva et al.</ext-link> also explained the importance of ExT in inducing epigenetic changes, however, the authors focused on the effects of resistance training. This elegant review initially explains how resistance training promotes changes at the physiological level, promoting beneficial concentric cardiac hypertrophy, improved vascular function, reduced blood pressure, normalization of blood glucose levels, among others. Subsequently, the text discusses how resistance training induces epigenetic modifications, altering miRNA expression, promoting histone acetylation and DNA methylation, generating various changes in signaling pathways in both healthy individuals and individuals with cardiovascular diseases.</p>
<p>In addition to the benefits promoted by aerobic exercise and resistance training, this Research Topic also addressed the effects of high-intensity interval training (HIIT). <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2025.1702247">Li and Dong</ext-link> showed that HIIT induces benefits in cardiovascular parameters by reducing systolic and diastolic blood pressure, modifying pulse wave velocity, and decreasing heart rate, improving vascular elasticity and endothelial function. In this sense, the interesting systematic review with meta-analysis by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2025.1736441">Zheng et al.</ext-link> shows that low-volume HIIT is a good and time-efficient strategy to efficiently improve the cardiovascular health of children and adolescents, significantly reducing body mass index, fat mass, waistline, weight, and improving VO2 max in these individuals.</p>
<p>Overall, the evidence gathered in this Research Topic represents valuable work that enriches the scientific literature on physiological and molecular adaptations induced by ExT. Further clinical and preclinical studies are essential for a deeper understanding of the various benefits orchestrated by different types of ExT on cardiovascular health and overall health, preventing the development and progression of CVDs.</p>
</body>
<back>
<sec sec-type="author-contributions" id="s1">
<title>Author contributions</title>
<p>AI-C: Writing &#x2013; original draft, Writing &#x2013; review and editing, Conceptualization. RA: Supervision, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="COI-statement" id="s3">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s4">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s5">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bocchi</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Bestetti</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Scanavacca</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Cunha Neto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Issa</surname>
<given-names>V. S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Chronic chagas heart disease management: from etiology to cardiomyopathy treatment</article-title>. <source>J. Am. Coll. Cardiol.</source> <volume>70</volume>, <fpage>1510</fpage>&#x2013;<lpage>1524</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2017.08.004</pub-id>
<pub-id pub-id-type="pmid">28911515</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Sousa</surname>
<given-names>R. A. L.</given-names>
</name>
<name>
<surname>Improta-Caria</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Regulation of microRNAs in Alzheimer&#xb4;s disease, type 2 diabetes, and aerobic exercise training</article-title>. <source>Metab. Brain Dis.</source> <volume>37</volume>, <fpage>559</fpage>&#x2013;<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-022-00903-y</pub-id>
<pub-id pub-id-type="pmid">35075500</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hastings</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Castro</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Abdul Kadir</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lerchenm&#xfc;ller</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Intrinsic and extrinsic contributors to the cardiac benefits of exercise</article-title>. <source>JACC Basic Transl. Sci.</source> <volume>9</volume>, <fpage>535</fpage>&#x2013;<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacbts.2023.07.011</pub-id>
<pub-id pub-id-type="pmid">38680954</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Improta-Caria</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>Joaquim</surname>
<given-names>V. H. A.</given-names>
</name>
<name>
<surname>De Sousa</surname>
<given-names>R. A. L.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>E. M.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>MicroRNAs regulating signaling pathways in cardiac fibrosis: potential role of the exercise training</article-title>. <source>Am. J. Physiol. - Hear. Circ. Physiol.</source> <volume>326</volume>, <fpage>H497</fpage>&#x2013;<lpage>H510</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00410.2023</pub-id>
<pub-id pub-id-type="pmid">38063810</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meira</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>De Souza Santos</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Do Esp&#xed;rito Santo</surname>
<given-names>R. F.</given-names>
</name>
<name>
<surname>Vasconcelos</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Orge</surname>
<given-names>I. D.</given-names>
</name>
<name>
<surname>Nonaka</surname>
<given-names>C. K. V.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Betulinic acid derivative BA5, attenuates inflammation and fibrosis in experimental chronic chagas disease cardiomyopathy by inducing IL-10 and M2 polarization</article-title>. <source>Front. Immunol.</source> <volume>10</volume>, <fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.01257</pub-id>
<pub-id pub-id-type="pmid">31244833</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paluch</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Boyer</surname>
<given-names>W. R.</given-names>
</name>
<name>
<surname>Franklin</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Laddu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lobelo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D. C.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Resistance exercise training in individuals with and without cardiovascular disease: 2023 update: a scientific statement from the American heart association</article-title>. <source>Circulation</source> <volume>149</volume>, <fpage>E217</fpage>&#x2013;<lpage>E231</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000001189</pub-id>
<pub-id pub-id-type="pmid">38059362</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Price</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>A review of guidelines for cardiac rehabilitation exercise programmes: is there an international consensus?</article-title> <source>arXiv</source>. <pub-id pub-id-type="doi">10.1177/2047487316657669</pub-id>
<pub-id pub-id-type="pmid">27353128</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roever</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cavalcante</surname>
<given-names>B. R. R.</given-names>
</name>
<name>
<surname>Improta-Caria</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Long-term consequences of COVID-19 on mental health and the impact of a physically active lifestyle: a narrative review</article-title>. <source>Ann. Gen. Psychiatry</source> <volume>22</volume>, <fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1186/s12991-023-00448-z</pub-id>
<pub-id pub-id-type="pmid">37170283</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stark</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>DeCleene</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Desai</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>C. O.</given-names>
</name>
<name>
<surname>Lara-Castor</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023</article-title>. <source>J. Am. Coll. Cardiol.</source> <volume>86</volume>, <fpage>2167</fpage>&#x2013;<lpage>2243</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2025.08.015</pub-id>
<pub-id pub-id-type="pmid">40990886</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wewege</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liou</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Keech</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>High-intensity interval training for patients with cardiovascular disease-is it safe? A systematic review</article-title>. <source>J. Am. Heart Assoc.</source> <volume>7</volume>, <fpage>1</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1161/JAHA.118.009305</pub-id>
<pub-id pub-id-type="pmid">30376749</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/22979/overview">Jacqueline Kathleen Phillips</ext-link>, Macquarie University, Australia</p>
</fn>
</fn-group>
</back>
</article>